Further studies with the 3xTg-AD mouse model showed that pioglitazone significantly decreases tau phosphorylated-positive neurons in the hippocampus and improved their cognitive impairment with the TZD treatment [24]. The gene discussed is MAPT; the disease is Alzheimer disease.